ARTICLE | Distillery Therapeutics
Therapeutics: Phospholipase A2 (PLA2)
January 14, 2016 8:00 AM UTC
Mouse studies identified a PLA2 inhibitor that could help treat liver fibrosis and non-alcoholic fatty liver disease (NAFLD). In a mouse model of chemical-induced liver damage, a small molecule inhibi...